Viewing Study NCT06303557


Ignite Creation Date: 2025-12-24 @ 6:49 PM
Ignite Modification Date: 2025-12-29 @ 1:25 PM
Study NCT ID: NCT06303557
Status: COMPLETED
Last Update Posted: 2025-11-26
First Post: 2024-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of ESPB on Intraoperative Remifentanil Consumption
Sponsor: Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Organization:

Study Overview

Official Title: Effect of ESPB on Intraoperative Remifentanil Consumption in Lumbar Spine Surgery
Status: COMPLETED
Status Verified Date: 2025-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In recent years, regional anesthesia techniques have also been frequently applied to patients for pain relief. Erector spinae plane block (ESPB), is among the regional anesthesia techniques frequently used in lumbar spine surgery.

General anesthesia (GA) is the main method of anesthesia for lumbar spine surgery. However, GA can only inhibit the projection system of the cortical limbic system or hypothalamic cortex. GA cannot completely block the transmission of peripheral noxious stimulus to the central nervous system and cannot effectively inhibit the intraoperative stress response. With the addition of peripheral blocks such as ESPB, lower remifentanil consumption, and more stable hemodynamics are expected by providing preemptive analgesia in patients.

As a result of all these; it was aimed to compare the intraoperative remifentanil consumption of patients who underwent preoperative ESPB in patients who will undergo lumbar spine surgery resection under GA with those who underwent postoperative ESPB.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: